Publications by authors named "David Bushnell"

Claim this Profile
S
Structure of the transcriptional co-activator SAGA complex, including the histone acetyltransferase module.
Rayees U H Mattoo, Dong-Hua Chen, David A Bushnell, Sagi Tamir, Roger D Kornberg

Mol Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.
Luis C Borbon, Scott K Sherman, Patrick J Breheny, Chandrikha Chandrasekharan, Yusuf Menda, David Bushnell

Ann Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial.
Maurizio Fava, Stephen M Stahl, Luca Pani, Sara De Martin, Andrew J Cutler, David Bushnell

J Clin Psychiatry· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cells.
Alexey V Stepanov, Jia Xie, Qiaoqiao Zhu, Zuyuan Shen, Wenji Su, David Bushnell

Nat Biomed Eng· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis.
Liene Friebe, Martin T Freitag, Martin Braun, Guillaume Nicolas, Andreas Bauman, David Bushnell

J Nucl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
Simron Singh, Thomas A Hope, Emily B Bergsland, Lisa Bodei, David L Bushnell

J Natl Cancer Inst· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
Charito Love, Neil B Desai, Tony Abraham, Kevin P Banks, Lisa Bodei, David L Bushnell

Am J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
Charito Love, Neil B Desai, Tony Abraham, Kevin P Banks, Lisa Bodei, David L Bushnell

Clin Nucl Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential for Increasing Uptake of Radiolabeled Ga-DOTATOC and I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat.
Janet H Pollard, Yusuf Menda, K D Zamba, Mark Madsen, M Sue O'Dorisio, David Bushnell

Cancer Biother Radiopharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of I-MIBG to PRRT (Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors.
David L Bushnell, Kellie L Bodeker, Thomas M O'Dorisio, Mark T Madsen, Yusuf Menda

J Nucl Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gold nanoparticles and tilt pairs to assess protein flexibility by cryo-electron microscopy.
Milind Jagota, Raphael J L Townshend, Lin-Woo Kang, David A Bushnell, Ron O Dror

Ultramicroscopy· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel AKR1C3 Specific Prodrug TH3424 With Potent Antitumor Activity in Liver Cancer.
Ping He, Chunnian Wang, Yanlan Wang, Caiyan Wang, Changhua Zhou, David A Bushnell

Clin Pharmacol Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-3 Å Cryo-EM Structures of Necrosis Virus Particles via the Use of Multipurpose TEM with Electron Counting Camera.
Chun-Hsiung Wang, Dong-Hua Chen, Shih-Hsin Huang, Yi-Min Wu, Yi-Yun Chen, David Bushnell

Int J Mol Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-specific-activity iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.
Joseph S Dillon, David Bushnell, Douglas E Laux

Future Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediator structure and conformation change.
Heqiao Zhang, Dong-Hua Chen, Rayees U H Mattoo, David A Bushnell, Yannan Wang

Mol Cell· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with Lu-DOTATATE.
Jonathan R Strosberg, Rajaventhan Srirajaskanthan, Ghassan El-Haddad, Edward M Wolin, Beth R Chasen, David L Bushnell

J Nucl Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The N-terminus of varicella-zoster virus glycoprotein B has a functional role in fusion.
Stefan L Oliver, Yi Xing, Dong-Hua Chen, Soung Hun Roh, Grigore D Pintilie, David A Bushnell

PLoS Pathog· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-Dotatate: an analysis of the NETTER-1 study.
Jonathan Strosberg, Pamela L Kunz, Andrew Hendifar, James Yao, David Bushnell

Eur J Nucl Med Mol Imaging· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation.
Stefan L Oliver, Yi Xing, Dong-Hua Chen, Soung Hun Roh, Grigore D Pintilie, David A Bushnell

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation.
Stefan L Oliver, Yi Xing, Dong-Hua Chen, Soung Hun Roh, Grigore D Pintilie, David A Bushnell

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview and Current Status of Peptide Receptor Radionuclide Therapy.
David L Bushnell, Kellie L Bodeker

Surg Oncol Clin N Am· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with Lu-DOTATATE.
Thomas A Hope, Amanda Abbott, Karen Colucci, David L Bushnell, Linda Gardner

J Nucl Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.
Yusuf Menda, Mark T Madsen, Thomas M O'Dorisio, John J Sunderland, G Leonard Watkins, David L Bushnell

J Nucl Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With Lu-Dotatate in the Phase III NETTER-1 Trial.
Jonathan Strosberg, Edward Wolin, Beth Chasen, Matthew Kulke, David Bushnell

J Clin Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis